The impact of liver steatosis on the severity of COVID-19 in patients with chronic coronary syndrome

The impact of liver steatosis on the severity of COVID-19 in patients with chronic coronary syndrome

Background. The coronavirus disease 2019 (COVID-19) remains one of the most pressing global health issues today. According to contemporary literature, COVID-19 may trigger a deterioration of liver function in patients with or without pre-existing liver diseases. It is known that COVID-19 can lead to...

Full description

Saved in:

Bibliographic Details
Main Authors:	M.M. Zhaivoronok, S.Ye. Mostovyi, O.M. Safonova
Format:	Article
Language:	English
Published:	Zaslavsky O.Yu. 2025-03-01
Series:	Gastroenterologìa
Subjects:	multidetector computed tomography covid-19 metabolic dysfunction-associated steatotic liver disease chronic coronary syndrome
Online Access:	https://gastro.zaslavsky.com.ua/index.php/journal/article/view/659
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ultrasound criteria for assessing the correction of metabolic-associated fatty liver disease and liver blood flow disorders using arginine in patients with coronary artery disease in combination with COVID-19
by: S.Ye. Mostovyi, et al.
Published: (2024-06-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

Augmenter of Liver Regeneration Crotonylation Assists in Mitochondria-ER Contact to Alleviate Hepatic SteatosisSummary
by: Xiao-lin Wang, et al.
Published: (2025-01-01)

Association of metabolic dysfunction-associated steatotic liver disease and steatosis-associated fibrosis estimator with subclinical coronary atherosclerosis: observation cohort study
by: Joonho Jeong, et al.
Published: (2025-07-01)

Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma
by: Young-Min Jee, et al.
Published: (2025-05-01)

Inter- and Intraobserver variability of attenuation coefficient measurement in innovative ultrasound diagnosis of metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
by: Maksym Zhaivoronok, et al.
Published: (2025-03-01)

A Comprehensive Assessment of Liver Transplant Trends and Outcomes Among Adults With Steatotic Liver Disease in the U.S.
by: Shyam Patel, et al.
Published: (2025-01-01)

Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review
by: Francisco Aguirre, et al.
Published: (2025-07-01)

Attenuation Based Quantitative Evaluation of Hepatic Steatosis Using US: Current Status and Future Perspective
by: Dong Ho Lee
Published: (2025-05-01)

A prospective comparison of two ultrasound attenuation imaging modes using different frequencies for assessing hepatic steatosis
by: Hyeon Ji Jang, et al.
Published: (2025-05-01)

Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study
by: Qiaoling Wu, et al.
Published: (2025-01-01)

Associations between circulating amino acids and metabolic dysfunction‐associated steatotic liver disease in individuals living with severe obesity
by: Ina Maltais‐Payette, et al.
Published: (2025-02-01)

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)

Genetic depletion of adipose-derived Isthmin-1 causes hepatic steatosis
by: Saranya C. Reghupaty, et al.
Published: (2025-08-01)

Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B
by: Zhiyuan Chen, et al.
Published: (2024-11-01)

Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level
by: Reza Hakkak, et al.
Published: (2024-10-01)

Association between periodontitis and mortality in participants with metabolic dysfunction-associated steatotic liver disease: results from NHANES
by: Zhaofu Zhang, et al.
Published: (2025-04-01)

Association between the Fatty Liver Index (FLI) and incident coronary heart disease: insights from a cohort study on the Chinese population
by: Ying Miao, et al.
Published: (2024-12-01)

Interventions targeting the gut-liver axis: A potential treatment strategy for metabolic dysfunction-associated steatotic liver disease
by: Pingping Jin, et al.
Published: (2025-07-01)

The evolution of international definitions of fatty liver disease and insights into the working definition and features of the 2024 Chinese guideline
by: Li CHEN, et al.
Published: (2025-06-01)

Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India
by: Umasankari S., et al.
Published: (2024-12-01)

Association of estimated glucose disposal rate with risk of future metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases: a prospective cohort study
by: Yan Li, et al.
Published: (2025-07-01)

Serum Irisin, Myostatin, and Myonectin Correlate with Metabolic Health Markers, Liver Disease Progression, and Blood Pressure in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Hypertension
by: Anna F. Sheptulina, et al.
Published: (2024-10-01)

Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer
by: Samuel O. Antwi, et al.
Published: (2025-01-01)

Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?
by: Doaa El Amrousy, et al.
Published: (2024-11-01)

Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
by: Ludovico Abenavoli, et al.
Published: (2024-09-01)

Unmet needs of metabolic dysfunction – Associated “fatty or steatotic” liver disease
by: Yu-Ming Cheng, et al.
Published: (2025-04-01)

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
by: Bruno Basil, et al.
Published: (2024-12-01)

Association of sarcopenia and physical activity on the severity of metabolic dysfunction-associated steatotic liver disease among United States adults: NHANES 2017 - 2018
by: Xiaodie Wei, et al.
Published: (2025-05-01)

Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yeo-Wool Kang, et al.
Published: (2024-11-01)

Comprehensive Analysis of Differentially Expressed Profiles of mRNA 5-Methylcytosine Modification in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yueying Yang, et al.
Published: (2025-04-01)

Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease
by: Sheng Lyu, et al.
Published: (2025-05-01)

Molecular spectroscopy of blood plasma differentiates metabolic dysfunction-associated steatohepatitis from steatosis
by: Barbora Nováková, et al.
Published: (2025-08-01)

Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
by: Chenyang Mu, et al.
Published: (2025-01-01)

Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention
by: Bassim El‐Sabawi, et al.
Published: (2025-05-01)

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study
by: Woo-Young Shin, et al.
Published: (2025-04-01)

Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
by: Weixiong Zhu, et al.
Published: (2025-07-01)

The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis
by: Polina Soluyanova, et al.
Published: (2024-11-01)